Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its ...

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

A single platform for agents and property marketers to order and publish MLS-ready 3D tours, photos, videos, floor plans, and ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...

During myogenic differentiation the cellular architecture and proteome of muscle stem cells and myoblasts undergo extensive remodeling. These molecular processes are only partially understood and ...

The company made its debut last year with a $51 million Series A and a licensing agreement with Astellas for a gene therapy candidate (KT430) for X-linked myotubular myopathy. Shortly after that ...

Copyright: © 2025 Published by Elsevier Ltd. The roll-out of gene therapy has not been without difficulties, mostly related to side-effects and complex technology ...

The pioneering gene therapy developer will be acquired by investment firms Carlyle Group and SK Capital for a fraction of what it was once worth. Rapid scientific advances have put the gene therapy ...

Feb. 25, 2025 — Investigators have conducted a multi-ancestry, whole genome sequencing association study of Alzheimer's disease and found evidence for 16 new susceptibility genes, expanding the ...